MMRF PRESS RELEASES
Multiple Myeloma Research Foundation (MMRF) Receives 11th Consecutive 4-Star Rating from Charity Navigator
MMRF Ranks in Top 1% of Nation’s Nonprofits for Outstanding Fiscal Management
Norwalk, CT — December 18, 2013
The Multiple Myeloma Research Foundation (MMRF) announced today that Charity Navigator has awarded the cancer research foundation an 11th consecutive 4-star rating, the highest acknowledgement possible, for financial responsibility and fiscal management. Earning the prestigious Charity Navigator 4-star rating for at least 11 consecutive years is an honor that less than one percent of charities nationwide have earned.
The Charity Navigator 4-star rating is a prestigious and coveted ranking that demonstrates exceptional commitment to donor accountability and transparency. Receiving this honor not only differentiates the MMRF from its peers but also demonstrates its dedication to maintaining donor trust and investment. By achieving the highest rating attainable from Charity Navigator, the nation’s premier charity evaluator, the MMRF is able to demonstrate to the public the exceptional intensity of its ongoing commitment to donors.
"We are continually inspired by our donors and the patients and families that we serve to accelerate the development of new treatment approaches for multiple myeloma and to ultimately find a cure,” said Walter M. Capone, President of the MMRF. “The MMRF works tirelessly to maximize every donation we receive – to be as fast and efficient as possible in order to extend patient lives.”
In addition to receiving the 4-star rating from Charity Navigator, the MMRF is one of only two cancer nonprofits to receive the top-rated A+ designation from CharityWatch. Formerly known as American Institute of Philanthropy, CharityWatch is an independent charity watchdog and information service. CharityWatch carefully scrutinizes the finances of nonprofits to provide donors with a clear understanding of how efficiently their cash donations are being spent in order to make more informed giving decisions.
Furthermore, the MMRF has received a "Best in America" Seal of Excellence from the Independent Charities of America, is a Guide Star Exchange Gold Participant, and is recognized by Philanthropedia as one of 16 expert-identified, high-impact nonprofits in the field of cancer. The MMRF continues to fulfill all of the Better Business Bureau's (BBB) Wise Giving Alliance Standards for Charity Accountability and has also received approval from the National Cancer Institute for the review process associated with its research grants program.
About the Multiple Myeloma Research Foundation (MMRF)
The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)(3) non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure. As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $240 million since its inception and directs 90% of total budget to research and related programming. As a result, the MMRF has been awarded Charity Navigator’s coveted four-star rating for 11 consecutive years, the highest designation for outstanding fiscal responsibility and exceptional efficiency. For more information about the MMRF, please visit: www.themmrf.org.
Anne Quinn Young, MPH